Global Diagnostic Nuclear Medicines Market Research Report 2023(Status and Outlook)
- Published Date: 2023-08-20
- Report ID: 146639
- Pages: 250
-
Format:
Report Overview
Diagnostic radiopharmaceuticals.Radiopharmaceuticals are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for thediagnosis
Prudent Markets latest report provides a deep insight into the global Diagnostic Nuclear Medicines market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porters five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Diagnostic Nuclear Medicines Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Diagnostic Nuclear Medicines market in any manner.
Global Diagnostic Nuclear Medicines Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Bracco Imaging
Bayer
Curium Pharmaceuticals
Nordion
Triad Isotopes
Lantheus
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Novartis
SIEMENS
Dongcheng
Navidea
Market Segmentation (by Type)
Tc-99m
F-18
Other
Market Segmentation (by Application)
Oncology
Cardiology
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Diagnostic Nuclear Medicines Market
Overview of the regional outlook of the Diagnostic Nuclear Medicines Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porters five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Diagnostic Nuclear Medicines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Diagnostic Nuclear Medicines
1.2 Key Market Segments
1.2.1 Diagnostic Nuclear Medicines Segment by Type
1.2.2 Diagnostic Nuclear Medicines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Diagnostic Nuclear Medicines Market Overview
2.1 Global Market Overview
2.1.1 Global Diagnostic Nuclear Medicines Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Diagnostic Nuclear Medicines Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Diagnostic Nuclear Medicines Market Competitive Landscape
3.1 Global Diagnostic Nuclear Medicines Sales by Manufacturers (2018-2023)
3.2 Global Diagnostic Nuclear Medicines Revenue Market Share by Manufacturers (2018-2023)
3.3 Diagnostic Nuclear Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Diagnostic Nuclear Medicines Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Diagnostic Nuclear Medicines Sales Sites, Area Served, Product Type
3.6 Diagnostic Nuclear Medicines Market Competitive Situation and Trends
3.6.1 Diagnostic Nuclear Medicines Market Concentration Rate
3.6.2 Global 5 and 10 Largest Diagnostic Nuclear Medicines Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Diagnostic Nuclear Medicines Industry Chain Analysis
4.1 Diagnostic Nuclear Medicines Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Diagnostic Nuclear Medicines Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Diagnostic Nuclear Medicines Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Diagnostic Nuclear Medicines Sales Market Share by Type (2018-2023)
6.3 Global Diagnostic Nuclear Medicines Market Size Market Share by Type (2018-2023)
6.4 Global Diagnostic Nuclear Medicines Price by Type (2018-2023)
7 Diagnostic Nuclear Medicines Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Diagnostic Nuclear Medicines Market Sales by Application (2018-2023)
7.3 Global Diagnostic Nuclear Medicines Market Size (M USD) by Application (2018-2023)
7.4 Global Diagnostic Nuclear Medicines Sales Growth Rate by Application (2018-2023)
8 Diagnostic Nuclear Medicines Market Segmentation by Region
8.1 Global Diagnostic Nuclear Medicines Sales by Region
8.1.1 Global Diagnostic Nuclear Medicines Sales by Region
8.1.2 Global Diagnostic Nuclear Medicines Sales Market Share by Region
8.2 North America
8.2.1 North America Diagnostic Nuclear Medicines Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Diagnostic Nuclear Medicines Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Diagnostic Nuclear Medicines Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Diagnostic Nuclear Medicines Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Diagnostic Nuclear Medicines Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Bracco Imaging
9.1.1 Bracco Imaging Diagnostic Nuclear Medicines Basic Information
9.1.2 Bracco Imaging Diagnostic Nuclear Medicines Product Overview
9.1.3 Bracco Imaging Diagnostic Nuclear Medicines Product Market Performance
9.1.4 Bracco Imaging Business Overview
9.1.5 Bracco Imaging Diagnostic Nuclear Medicines SWOT Analysis
9.1.6 Bracco Imaging Recent Developments
9.2 Bayer
9.2.1 Bayer Diagnostic Nuclear Medicines Basic Information
9.2.2 Bayer Diagnostic Nuclear Medicines Product Overview
9.2.3 Bayer Diagnostic Nuclear Medicines Product Market Performance
9.2.4 Bayer Business Overview
9.2.5 Bayer Diagnostic Nuclear Medicines SWOT Analysis
9.2.6 Bayer Recent Developments
9.3 Curium Pharmaceuticals
9.3.1 Curium Pharmaceuticals Diagnostic Nuclear Medicines Basic Information
9.3.2 Curium Pharmaceuticals Diagnostic Nuclear Medicines Product Overview
9.3.3 Curium Pharmaceuticals Diagnostic Nuclear Medicines Product Market Performance
9.3.4 Curium Pharmaceuticals Business Overview
9.3.5 Curium Pharmaceuticals Diagnostic Nuclear Medicines SWOT Analysis
9.3.6 Curium Pharmaceuticals Recent Developments
9.4 Nordion
9.4.1 Nordion Diagnostic Nuclear Medicines Basic Information
9.4.2 Nordion Diagnostic Nuclear Medicines Product Overview
9.4.3 Nordion Diagnostic Nuclear Medicines Product Market Performance
9.4.4 Nordion Business Overview
9.4.5 Nordion Diagnostic Nuclear Medicines SWOT Analysis
9.4.6 Nordion Recent Developments
9.5 Triad Isotopes
9.5.1 Triad Isotopes Diagnostic Nuclear Medicines Basic Information
9.5.2 Triad Isotopes Diagnostic Nuclear Medicines Product Overview
9.5.3 Triad Isotopes Diagnostic Nuclear Medicines Product Market Performance
9.5.4 Triad Isotopes Business Overview
9.5.5 Triad Isotopes Diagnostic Nuclear Medicines SWOT Analysis
9.5.6 Triad Isotopes Recent Developments
9.6 Lantheus
9.6.1 Lantheus Diagnostic Nuclear Medicines Basic Information
9.6.2 Lantheus Diagnostic Nuclear Medicines Product Overview
9.6.3 Lantheus Diagnostic Nuclear Medicines Product Market Performance
9.6.4 Lantheus Business Overview
9.6.5 Lantheus Recent Developments
9.7 GE Healthcare
9.7.1 GE Healthcare Diagnostic Nuclear Medicines Basic Information
9.7.2 GE Healthcare Diagnostic Nuclear Medicines Product Overview
9.7.3 GE Healthcare Diagnostic Nuclear Medicines Product Market Performance
9.7.4 GE Healthcare Business Overview
9.7.5 GE Healthcare Recent Developments
9.8 China Isotope and Radiation
9.8.1 China Isotope and Radiation Diagnostic Nuclear Medicines Basic Information
9.8.2 China Isotope and Radiation Diagnostic Nuclear Medicines Product Overview
9.8.3 China Isotope and Radiation Diagnostic Nuclear Medicines Product Market Performance
9.8.4 China Isotope and Radiation Business Overview
9.8.5 China Isotope and Radiation Recent Developments
9.9 Jubilant Pharma
9.9.1 Jubilant Pharma Diagnostic Nuclear Medicines Basic Information
9.9.2 Jubilant Pharma Diagnostic Nuclear Medicines Product Overview
9.9.3 Jubilant Pharma Diagnostic Nuclear Medicines Product Market Performance
9.9.4 Jubilant Pharma Business Overview
9.9.5 Jubilant Pharma Recent Developments
9.10 Eli Lilly
9.10.1 Eli Lilly Diagnostic Nuclear Medicines Basic Information
9.10.2 Eli Lilly Diagnostic Nuclear Medicines Product Overview
9.10.3 Eli Lilly Diagnostic Nuclear Medicines Product Market Performance
9.10.4 Eli Lilly Business Overview
9.10.5 Eli Lilly Recent Developments
9.11 Novartis
9.11.1 Novartis Diagnostic Nuclear Medicines Basic Information
9.11.2 Novartis Diagnostic Nuclear Medicines Product Overview
9.11.3 Novartis Diagnostic Nuclear Medicines Product Market Performance
9.11.4 Novartis Business Overview
9.11.5 Novartis Recent Developments
9.12 SIEMENS
9.12.1 SIEMENS Diagnostic Nuclear Medicines Basic Information
9.12.2 SIEMENS Diagnostic Nuclear Medicines Product Overview
9.12.3 SIEMENS Diagnostic Nuclear Medicines Product Market Performance
9.12.4 SIEMENS Business Overview
9.12.5 SIEMENS Recent Developments
9.13 Dongcheng
9.13.1 Dongcheng Diagnostic Nuclear Medicines Basic Information
9.13.2 Dongcheng Diagnostic Nuclear Medicines Product Overview
9.13.3 Dongcheng Diagnostic Nuclear Medicines Product Market Performance
9.13.4 Dongcheng Business Overview
9.13.5 Dongcheng Recent Developments
9.14 Navidea
9.14.1 Navidea Diagnostic Nuclear Medicines Basic Information
9.14.2 Navidea Diagnostic Nuclear Medicines Product Overview
9.14.3 Navidea Diagnostic Nuclear Medicines Product Market Performance
9.14.4 Navidea Business Overview
9.14.5 Navidea Recent Developments
10 Diagnostic Nuclear Medicines Market Forecast by Region
10.1 Global Diagnostic Nuclear Medicines Market Size Forecast
10.2 Global Diagnostic Nuclear Medicines Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Diagnostic Nuclear Medicines Market Size Forecast by Country
10.2.3 Asia Pacific Diagnostic Nuclear Medicines Market Size Forecast by Region
10.2.4 South America Diagnostic Nuclear Medicines Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Diagnostic Nuclear Medicines by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global Diagnostic Nuclear Medicines Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Diagnostic Nuclear Medicines by Type (2024-2029)
11.1.2 Global Diagnostic Nuclear Medicines Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Diagnostic Nuclear Medicines by Type (2024-2029)
11.2 Global Diagnostic Nuclear Medicines Market Forecast by Application (2024-2029)
11.2.1 Global Diagnostic Nuclear Medicines Sales (K MT) Forecast by Application
11.2.2 Global Diagnostic Nuclear Medicines Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
